1. Curtiss PH Jr, Kincaid WE. Transitory demineralization of the hip in pregnancy: a report of three cases. J Bone Joint Surg Am. 1959; 41-A:1327–33.
2. Van Wagenen K, Pritchard P, Taylor JA. Transient osteoporosis of the hip: a case report. J Can Chiropr Assoc. 2013; 57:116–22.
3. Ma FY, Falkenberg M. Case reports: transient osteoporosis of the hip: an atypical case. Clin Orthop Relat Res. 2006; 445:245–9.
4. Asadipooya K, Graves L, Greene LW. Transient osteoporosis of the hip: review of the literature. Osteoporos Int. 2017; 28:1805–16.
5. Rosen RA. Transitory demineralization of the femoral head. Radiology. 1970; 94:509–12.
6. Plenk H Jr, Hofmann S, Eschberger J, Gstettner M, Kramer J, Schneider W, et al. Histomorphology and bone morphometry of the bone marrow edema syndrome of the hip. Clin Orthop Relat Res. 1997; (334):73–84.
7. Koo KH, Jeong ST, Jones JP Jr. Borderline necrosis of the femoral head. Clin Orthop Relat Res. 1999; (358):158–65.
8. Manara M, Varenna M. A clinical overview of bone marrow edema. Reumatismo. 2014; 66:184–96.
9. Orth P, Anagnostakos K. Coagulation abnormalities in osteonecrosis and bone marrow edema syndrome. Orthopedics. 2013; 36:290–300.
10. Diwanji SR, Cho YJ, Xin ZF, Yoon TR. Conservative treatment for transient osteoporosis of the hip in middle-aged women. Singapore Med J. 2008; 49:e17–21.
11. Daniel RS, Farrar EK, Norton HR, Nussbaum AI. Bilateral transient osteoporosis of the talus in pregnancy. Osteoporos Int. 2009; 20:1973–5.
12. Jennings PE, O’Malley BP, Griffin KE, Northover B, Rosenthal FD. Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for “tissue thyrotoxicosis”. Br Med J (Clin Res Ed). 1984; 289:1645–7.
13. Dunstan CR, Evans RA, Somers NM. Bone death in transient regional osteoporosis. Bone. 1992; 13:161–5.
14. Flores-Robles BJ, Sanz-Sanz J, Sanabria-Sanchinel AA, Huntley-Pascual D, Andréu Sánchez JL, Campos Esteban J, et al. Zoledronic acid treatment in primary bone marrow edema syndrome. J Pain Palliat Care Pharmacother. 2017; 31:52–6.
15. Emad Y, Ragab Y, El-Shaarawy N, Rasker JJ. Transient osteoporosis of the hip, complete resolution after treatment with alendronate as observed by MRI description of eight cases and review of the literature. Clin Rheumatol. 2012; 31:1641–7.
16. Kibbi L, Touma Z, Khoury N, Arayssi T. Oral bisphosphonates in treatment of transient osteoporosis. Clin Rheumatol. 2008; 27:529–32.
17. Schapira D, Braun Moscovici Y, Gutierrez G, Nahir AM. Severe transient osteoporosis of the hip during pregnancy: successful treatment with intravenous biphosphonates. Clin Exp Rheumatol. 2003; 21:107–10.
18. Yagishita K, Jinno T, Koga D, Kato T, Enomoto M, Kato T, et al. Transient osteoporosis of the hip treated with hyperbaric oxygen therapy: a case series. Undersea Hyperb Med. 2016; 43:847–54.
19. Bashaireh KM, Aldarwish FM, Al-Omari AA, Albashaireh MA, Hajjat M, Al-Ebbini MA, et al. Transient osteoporosis of the hip: risk and therapy. Open Access Rheumatol. 2020; 12:1–8.
20. Hadji P, Boekhoff J, Hahn M, Hellmeyer L, Hars O, Kyvernitakis I. Pregnancy-associated transient osteoporosis of the hip: results of a case-control study. Arch Osteoporos. 2017; 12:11.